Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048576770> ?p ?o ?g. }
- W2048576770 endingPage "81" @default.
- W2048576770 startingPage "71" @default.
- W2048576770 abstract "Combined modality therapy is gaining acceptance for treating stage 3 and 4A thymic tumors. Also, specific subsets of stage 2 tumors deserve particular attention. Single-center experiences demonstrate that there are some advantages in selected groups of patients. The overall relatively low complete response rate, however, imposes the search for better systemic therapy to optimize results. In fact, although thymic tumors are responsive to different cytotoxic regimens, none has been demonstrated to be the ideal one. New therapies and strategies should be designed and tested in large-scale multicenter prospective trials. Among the others, epidermal growth factor receptor inhibitors have shown some clinical response, because EGFR is overexpressed in thymoma. c-KIT is overexpressed in thymic carcinoma. Although in a recent study a clinical response to imatinib has been reported, results of a prospective study in patients who have thymic carcinoma are pending. Clinical responses have been reported also to other tyrosine kinase inhibitors, such as dasatinib. Other reports have stressed the presence of an up-regulation of COX-2 with a potential separate therapeutic pathway. Other markers, such as the expression of thymidine synthase and dihydropyrimidine dehydrogenase, which predict sensitivity to 5-fluoruracil-based chemotherapy, were not correlated with the clinicopathological characteristics in a series of thymomas. These new therapies should be incorporated in a standardized approach that goes from a careful assessment of histology, staging, and lymph node status, and a constructive and nonempiric cooperation between the oncologist, radiotherapist, pathologist, and thoracic surgeon." @default.
- W2048576770 created "2016-06-24" @default.
- W2048576770 creator A5025153023 @default.
- W2048576770 creator A5088949535 @default.
- W2048576770 creator A5089270717 @default.
- W2048576770 date "2009-02-01" @default.
- W2048576770 modified "2023-09-27" @default.
- W2048576770 title "Multimodality Treatment of Thymic Tumors" @default.
- W2048576770 cites W1540342753 @default.
- W2048576770 cites W1572569260 @default.
- W2048576770 cites W165982544 @default.
- W2048576770 cites W1819549830 @default.
- W2048576770 cites W1909030710 @default.
- W2048576770 cites W1964521612 @default.
- W2048576770 cites W1964640858 @default.
- W2048576770 cites W1966775137 @default.
- W2048576770 cites W1967836058 @default.
- W2048576770 cites W1973959930 @default.
- W2048576770 cites W1977355447 @default.
- W2048576770 cites W1977501283 @default.
- W2048576770 cites W1980743422 @default.
- W2048576770 cites W1981999692 @default.
- W2048576770 cites W1982876479 @default.
- W2048576770 cites W1983886870 @default.
- W2048576770 cites W1984737590 @default.
- W2048576770 cites W1988880367 @default.
- W2048576770 cites W1989135175 @default.
- W2048576770 cites W1990689337 @default.
- W2048576770 cites W1997076019 @default.
- W2048576770 cites W1998263709 @default.
- W2048576770 cites W2005940138 @default.
- W2048576770 cites W2006286945 @default.
- W2048576770 cites W2006610888 @default.
- W2048576770 cites W2006991022 @default.
- W2048576770 cites W2008957171 @default.
- W2048576770 cites W2012510274 @default.
- W2048576770 cites W2015624964 @default.
- W2048576770 cites W2017923280 @default.
- W2048576770 cites W2018509765 @default.
- W2048576770 cites W2019345797 @default.
- W2048576770 cites W2019684920 @default.
- W2048576770 cites W2021691838 @default.
- W2048576770 cites W2023038782 @default.
- W2048576770 cites W2024124632 @default.
- W2048576770 cites W2024584401 @default.
- W2048576770 cites W2028811731 @default.
- W2048576770 cites W2031075790 @default.
- W2048576770 cites W2043855663 @default.
- W2048576770 cites W2046765068 @default.
- W2048576770 cites W2047064667 @default.
- W2048576770 cites W2047099048 @default.
- W2048576770 cites W2049519367 @default.
- W2048576770 cites W2049885575 @default.
- W2048576770 cites W2055957058 @default.
- W2048576770 cites W2056129513 @default.
- W2048576770 cites W2060533914 @default.
- W2048576770 cites W2064628166 @default.
- W2048576770 cites W2065810879 @default.
- W2048576770 cites W2067780695 @default.
- W2048576770 cites W2069083978 @default.
- W2048576770 cites W2070382937 @default.
- W2048576770 cites W2071018586 @default.
- W2048576770 cites W2072497490 @default.
- W2048576770 cites W2072903953 @default.
- W2048576770 cites W2073530996 @default.
- W2048576770 cites W2077237828 @default.
- W2048576770 cites W2077682361 @default.
- W2048576770 cites W2078268107 @default.
- W2048576770 cites W2079993247 @default.
- W2048576770 cites W2080497279 @default.
- W2048576770 cites W2083719902 @default.
- W2048576770 cites W2086023535 @default.
- W2048576770 cites W2088178968 @default.
- W2048576770 cites W2089168852 @default.
- W2048576770 cites W2091920506 @default.
- W2048576770 cites W2095398749 @default.
- W2048576770 cites W2096135115 @default.
- W2048576770 cites W2096261383 @default.
- W2048576770 cites W2100345536 @default.
- W2048576770 cites W2104048219 @default.
- W2048576770 cites W2104738859 @default.
- W2048576770 cites W2108263472 @default.
- W2048576770 cites W2112738862 @default.
- W2048576770 cites W2120750357 @default.
- W2048576770 cites W2133536006 @default.
- W2048576770 cites W2141720524 @default.
- W2048576770 cites W2141844053 @default.
- W2048576770 cites W2143515208 @default.
- W2048576770 cites W2147556117 @default.
- W2048576770 cites W2148086522 @default.
- W2048576770 cites W2150210290 @default.
- W2048576770 cites W2150775354 @default.
- W2048576770 cites W2153426514 @default.
- W2048576770 cites W2154563289 @default.
- W2048576770 cites W2163263812 @default.
- W2048576770 cites W2164784424 @default.
- W2048576770 cites W2165578270 @default.
- W2048576770 cites W2167445450 @default.